SANTA MONICA, Calif. — GoodRx, a leading platform for medication savings in the U.S., has appointed Laura Jensen as its new Chief Commercial Officer and President of Pharma Solutions, effective July 28, 2025. Jensen brings with her extensive experience from Amazon Pharmacy, where she played a pivotal role in redefining how patients access and manage medications.
In her new role, Jensen will oversee GoodRx’s Pharma Manufacturer Solutions division and lead strategic initiatives aimed at expanding the company’s partnerships within the pharmaceutical industry. Her focus will be on helping drugmakers modernize their go-to-market strategies and improve direct-to-patient engagement through the GoodRx platform.
“We are thrilled to have Laura join our executive team,” said Wendy Barnes, President and CEO of GoodRx. “Her deep experience across pharmaceutical, consumer health, and pharmacy ecosystems—combined with her passion for improving patient access—makes her uniquely suited to lead our growing Pharma Manufacturer Solutions business. We are confident Laura will help us deepen our impact and accelerate growth, ultimately helping the industry reimagine how patients access the care they need.”
At Amazon Pharmacy, Jensen served as Head of Manufacturer & Prescriber Business Development, where she led strategic partnerships for both Amazon Pharmacy and PillPack. Her team was instrumental in developing integrated solutions that connected prescribers with pharmacy workflows, driving innovation in medication access and patient engagement.
Prior to Amazon, Jensen held leadership roles at pharmaceutical companies including UCB and GlaxoSmithKline. There, she led initiatives across sales, marketing, operations, and commercial innovation, giving her a comprehensive view of the healthcare landscape.
“Now, more than ever, pharma companies recognize that patients are looking for new ways to access their medications in the changing ecosystem of healthcare,” said Jensen. “I’m thrilled to join the GoodRx team, which has built the most trusted and widely used medication savings platform in the country. By combining GoodRx’s reach and scale with innovative access solutions, we have an incredible opportunity to help more people start and stay on the treatments they need.”
Jensen’s appointment signals GoodRx’s continued investment in strengthening its pharmaceutical partnerships and enhancing patient affordability and access solutions amid an evolving healthcare market.
